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Tuberculosis (TB) is a serious infectious disease caused by the inhalation of the pathogen Mycobacterium 
tuberculosis (M.tb), and affects patients globally and is one of the biggest causes of death, along with infection 
by the Human Immunodeficiency Virus (HIV). The majority of cases of TB in 2014 were seen to occur within 
the South East Asian and Western Pacific regions, with approximately 58% of incident cases reported in these 
regions. Recently, the rise of multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB has made the 
situation even more serious. MDR-TB refer to M.tb pathogen that are resistant to at least both isoniazid and 
rifampicin, the two most powerful first-line anti-TB drugs. XDR-TB refers to M.tb pathogen that are resistant to 
one fluoroquinolone and a second-line injectable anti-TB drug, in addition to both isoniazid and rifampicin. These 
factors make TB extremely difficult to control and treat. The immunopathogenesis of TB involves the actions of 
a number of immune cells and cytokines in the host that result in the formation of a granuloma structure, with the 
core of the structure made up of macrophages that have up-taken the pathogen. The granuloma is thought to act 
as a barrier to contain the bacteria and stop the infection from spreading. A patient would enter a period of 
dormancy in containment of the M.tb pathogen is successful, but will suffer a re-activation of the disease should 
containment by the granuloma fail.  
 An estimated one-third of the world’s population is infected with the M.tb pathogen, however, only about 
5-15% of those infected ever develop the clinical symptoms of TB disease within two years, leading to the 
speculation that there may be genetic factors involved in the host susceptibility to TB. Previous studies done using 
twins also showed that there was a 2.5-fold higher concordance rate for TB in monozygotic twins compared to 
dizygotic twins, further reinforcing the idea that genetic factors are involved in TB susceptibility. Numerous 
studies have been conducted in a many different populations to try to identify these genetic factors, including 
genome-wide linkage studies (GWLS), candidate gene association studies and more recently, genome-wide 
association studies (GWAS). A large number of genes, genetic regions and loci have been seen to be associated 
with TB susceptibility, however, the lack of replicability among the regions and genes identified among the 
different populations point to the complex nature of host genetic susceptibility factors for TB. Additionally, many 
studies have also been conducted in the genome of the M.tb pathogen, and many mutations in the pathogen genome 
have been identified that confers resistance to anti-TB drugs. However, pathogen genome mutations cannot 
completely explain susceptibility of the host to drug-resistant TB, and studies to identify host genetic susceptibility 
factors are also needed. A number of studies have been conducted in the Human Leukocyte Antigen (HLA) region 
and a number of HLA alleles have been identified in the Indian and Korean populations, as well as the SLC11A1 
gene in Japanese, to be associated with drug-resistant TB susceptibility of the host. The present study consisted 
of two parts. In the first part, I attempted to identify new, as-yet un-identified genetic factors affecting TB 
susceptibility in Thais, using next-generation sequencing (NGS) and a variant detection, filtering and prioritization 
workflow. In the second part of the study, I conducted a GWAS in an Indonesian population to search for genetic 
susceptibility factors affecting host susceptibility to drug-resistant TB.   
A previous GWLS conducted in Thai family samples identified a susceptibility region on the 
chromosome (chr.) 5q23.2-31.2 region that showed suggestive evidence of linkage for susceptibility for TB. 
Subsequently, another single nucleotide polymorphism (SNP) association study was conducted in Thai family 
samples on the chr.5q31 region, which was part of the earlier identified susceptibility region. A number of SNP 
haplotypes were identified to be significantly associated with TB susceptibility. For the first part of this current 
study, a candidate region was defined by centering on the top SNP in the most significantly associated SNP 
haplotype in the earlier Thai family association study and extended in both directions up to approximately 1Mb. 
This candidate region was captured and extracted from 18 Thai samples using custom-made in-solution 
hybridization probes and subsequently sequenced using the Ion Torrent Personal Genome Machine (PGM) NGS 
platform. Two software were used to detect variants from the sequencing data. After applying stringent filtering 
criteria, such as requiring at least 20x read depth coverage of detected variants, and variants needing to be detected 
in both software as well as seen in at least two or more sequenced samples, a total of 904 variants were identified. 
Variants that were located in genes with minor allele frequencies (MAF) of at least 5% in the 1000 Genomes 
Project Southern Chinese (CHS) population were prioritized, and SNPs that were previously studied in another 
GWAS done in Thais were excluded. A total of 188 SNPs remained after this filtering step and from this list, 35 
tagSNPs were identified before being put through the Ensembl Variant Effect Predictor (VEP) software to further 
prioritize candidate SNPs according to their predicted functional consequences. Five SNPs were identified as 
candidates for further analysis, and the NGS calls for these SNPs were confirmed using Sanger direct sequencing, 
before a further case-control association analysis was conducted using the Taqman genotyping assay in another 
set of 663 Thai TB cases and 774 controls. It was observed from the association analysis that a SNP, located in 
the 3’-Untranslated Region (UTR) of a gene, showed moderate evidence of association with TB susceptibility in 
the genotypic model (p = 0.012) and the dominant model (p = 0.029, OR = 1.43, 95% CI = 1.04 – 1.96).  
In the second part of the study, a GWAS was conducted using the Illumina HumanOmniExpressExome-
8 v1.2 BeadChip array, that interrogates approximately 960,000 SNPs across the human genome. The case 
samples used in the study were 160 drug-resistant TB cases and control samples consisted of 192 drug-sensitive 
TB patients. The samples were collected from the Indonesian islands of Java and Madura. Quality control of the 
data was conducted, which included filtering out SNPs that had less than 99% genotype call rates and excluding 
SNPs that had MAF > 5%, as well as SNPs that failed the Hardy-Weinberg Equilibrium test. Samples which had 
call rates of less than 99% were also excluded, as well as those that showed cryptic relatedness. Principal 
component Analysis (PCA) also identified a number of individuals that showed some genetic differences from 
the main Indonesian sample group and these samples were excluded. Association analysis was conducted on the 
genotyped SNPs after quality control of the data was performed. The association analysis identified ten SNPs that 
showed suggestive evidence of association (p < 1.0 x 10-05) with drug-resistant TB, with the most significant 
association seen for a SNP located in a gene on chr. 4 (p-value = 2.83 x 10-07, OR = 2.33). A number of genes 
were also observed to contain a number of SNPs showing suggestive and moderate (p < 1.0 x 10-04) evidence of 
association.  
Regional genotype imputation was conducted for these gene regions and for regions that contained SNPs 
with suggestive evidence of association to try to identify potential un-typed SNPs that may show more significance 
than the ones in the GWAS. An imputed SNP located in chr. 6 was seen to have a lower p-value (pimputation =2.04 
x 10-06) compared to the most significant SNP seen in the GWAS for that region. The association results SNPs 
showing suggestive evidence of association, as well as the imputed SNP, were validated using Taqman genotyping, 
and genotype concordance between the two genotyping platform was high (~98%). Given the previous reports of 
association between HLA alleles and drug-resistant TB, HLA allele imputation was conducted on the GWAS 
results. HLA imputation identified a number of class I and class II HLA alleles showing moderate association with 
drug-resistant TB in Indonesians, with the most significant associations seen in the class I HLA-B and HLA-C 
alleles (p = 0.003). Furthermore, due to previous reports of association between the BTNL2 gene and TB, as well 
as signals in some class II HLA alleles being in high linkage disequilibrium with signals in BTNL2, a conditional 
analysis for the HLA region on chr. 6 on SNPs showing moderate association in BTNL2 was conducted. A SNP, 
located within a cluster of class II HLA genes, was seen to have a more significant p-value (p = 1.29 x 10-04) 
compared to the original GWAS results (p = 1.53 x 10-01). However, the main signals in the region were still seen 
to be SNPs in the BTNL2 gene.  
A gene-based association analysis was also conducted using the results of the GWAS using the VEGAS2 
software, and significant results of the gene-based association analysis (genes with p-values < 0.01) were used to 
conduct gene pathway, process networks, and gene ontology enrichment analysis. The enrichment analysis was 
conducted using the Metacore program. A number of gene pathways, process networks, and gene ontologies 
related to immune system function and immune response to bacterial infection were seen to be significantly 
enriched (p < 0.05). The genes identified by the GWAS may have functions related to kidney function and 
subsequent drug clearance from blood plasma, granuloma formation or maintenance, as well as also potentially 
being involved in apoptosis and necrotization of the granuloma core, possibly leading to lowered drug penetration 
and exposure and increasing the risk and chance of developing drug-resistant TB. Further studies are required to 
elucidate the functional effects of the SNPs on the genes. The results of the enrichment analyses also identified a 
number of pathways that may be interesting avenues for further investigation into their effects on the development 
of drug-resistant TB.  
In conclusion, the present study manages to identify a new 3’-UTR SNP, located in a candidate 
susceptibility region on chr.5q31.1, that showed moderate evidence of association with TB in a Thai population. 
The variant prioritization and filtering workflow was successful in identifying novel SNPs as candidates from 
NGS data and it would be worthwhile to further expand and improve the workflow. This study is also the first 
report of a GWAS for drug-resistant TB in an Indonesian population, and identified a number of potential genes 
and gene pathways, biological process networks, and gene ontologies that are associated with the development of 
drug-resistant TB.   
 
